Finally, to explore the clinical relevance and significance of TRIM21, we first performed immunohistochemical (IHC) staining in 46 NPC tissue samples and found that the expression of TRIM21 was negatively associated with VDAC2 expression (Fig. 7a, b). The gene discussed is TRIM21; the disease is nasopharyngeal carcinoma.